What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Takanori Kanai spends much of his time researching Immunology, Colitis, Immune system, Internal medicine and Lamina propria.
His biological study spans a wide range of topics, including Intestinal mucosa and Inflammatory bowel disease.
His Colitis research integrates issues from Inflammation, Receptor, T lymphocyte and Antibody.
The Immune system study combines topics in areas such as Gut flora and Antigen.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology, Surgery and MEDLINE.
His research integrates issues of Interleukin 18, Integrin alpha M, Peripheral blood mononuclear cell, Interleukin and Macrophage in his study of Lamina propria.
His most cited work include:
- Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids (557 citations)
- Damaged epithelia regenerated by bone marrow–derived cells in the human gastrointestinal tract (353 citations)
- The gut microbiota and inflammatory bowel disease. (312 citations)
What are the main themes of his work throughout his whole career to date?
Takanori Kanai mainly investigates Internal medicine, Gastroenterology, Immunology, Ulcerative colitis and Colitis.
In the subject of general Internal medicine, his work in Crohn's disease, Colonoscopy and Adverse effect is often linked to In patient, thereby combining diverse domains of study.
His Gastroenterology research incorporates elements of Odds ratio, Randomized controlled trial and Infliximab.
Takanori Kanai has included themes like Lamina propria and Inflammatory bowel disease in his Immunology study.
The subject of his Ulcerative colitis research is within the realm of Pathology.
His Colitis study integrates concerns from other disciplines, such as Molecular biology and Adoptive cell transfer.
He most often published in these fields:
- Internal medicine (41.79%)
- Gastroenterology (28.00%)
- Immunology (25.79%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (41.79%)
- Gastroenterology (28.00%)
- Ulcerative colitis (17.52%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Gastroenterology, Ulcerative colitis, In patient and Adverse effect.
His study involves Crohn's disease, Confidence interval, Odds ratio, Clinical trial and Randomized controlled trial, a branch of Internal medicine.
His work deals with themes such as Pharmacokinetics and Pancreas, which intersect with Gastroenterology.
His studies in Ulcerative colitis integrate themes in fields like Colonoscopy, Colitis and Calprotectin.
His Colitis research is classified as research in Immunology.
The Adverse effect study combines topics in areas such as Clinical endpoint and Surgery.
Between 2017 and 2021, his most popular works were:
- Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression (182 citations)
- Evidence-based clinical practice guidelines for inflammatory bowel disease (160 citations)
- Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis (77 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Takanori Kanai mainly investigates Internal medicine, Colitis, Immunology, Ulcerative colitis and Immune system.
He combines topics linked to Gastroenterology with his work on Internal medicine.
His biological study spans a wide range of topics, including Cancer, Inflammatory bowel disease, Immune checkpoint inhibitors, Diarrhea and Epigenetics.
His Immunology research incorporates themes from Fibrosis and Transcription factor.
The concepts of his Ulcerative colitis study are interwoven with issues in Dysbiosis, Liver disease, Hepatology, Colonoscopy and Cohort.
Takanori Kanai has included themes like Cytokine, Liver injury, Lung and Gut flora in his Immune system study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
